- Details
- Description
Strength:
10 mg
Composition:
Brensocatib 10 mg
Treatment:
Non-cystic fibrosis bronchiectasis (NCFB)
Form:
Tablet
Brand:
LuciBren
Quantity Unit:
Tablets
Manufacturer:
Luci Pharma
LuciBren 10 (Brensocatib) is a targeted anti-inflammatory medicine containing brensocatib, a reversible inhibitor of dipeptidyl peptidase 1 (DPP-1). By inhibiting DPP-1, it reduces the activation of neutrophil serine proteases that contribute to inflammation and tissue damage.
Brensocatib is used for the treatment of non-cystic fibrosis bronchiectasis (bronchiectasis) in appropriate patients. By reducing neutrophil-driven inflammation, it may help decrease pulmonary exacerbations and support respiratory health.
LuciBren 10 is an oral medicine and should be used under the supervision of a qualified healthcare professional according to the approved indication and prescribed treatment regimen.
